Table of Contents
<< Previous Issue | May 2011 (Vol: 2011, Issue: 5) | Next Issue >> |
- Section: Cartoons
-
Poker Game
- Section: Distribution & Marketing
-
Mundipharma Gains Commercialisation Rights to Allos Therapeutics’ Folotyn® Outside of North America
- Section: Licensing
-
Allergan Licenses Molecular Partners’ Mid-Stage Ophthalmology Drug in US$420 M Deal
-
Glenmark Pharmaceuticals Out-Licenses Anti-Inflammatory Antibody to Sanofi-aventis
- Section: Mergers & Acquisitions
-
Teva Looks to Diversify its Branded Drugs Portfolio with US$6.8 B Cephalon Acquisition
-
Johnson & Johnson to Acquire Synthes for US$21.3 B in Cash and Stock
-
Alkermes to Purchase Elan’s Drug Delivery Unit for US$960 M in Cash and Stock
-
Takeda Goes Global with US$13.7 B Nycomed Acquisition
-
Teva Agrees to Acquire Taiyo to Become Key Generics Player in Japan